Cancer in Inflammatory Bowel Disease

Area of Science:

• Gastroenterology and Oncology
• Chronic Inflammatory Diseases

Background:

• Inflammatory bowel diseases (IBD), encompassing Crohn disease and ulcerative colitis, are chronic gastrointestinal inflammatory conditions.
• IBD patients exhibit elevated risks for both intestinal malignancies (colorectal, small bowel adenocarcinoma, lymphoma, anal cancer) and extraintestinal cancers (cholangiocarcinoma, skin, hematologic, genitourinary, cervical, prostate).

Purpose of the Study:

• To summarize the spectrum of cancer risks in patients diagnosed with inflammatory bowel diseases.
• To outline the diagnostic and management approaches for colorectal neoplasia in the context of IBD.
• To provide guidance on managing IBD patients who have active or recent cancer diagnoses.

Main Methods:

• Literature review and synthesis of existing research on IBD and cancer risk.
• Analysis of diagnostic criteria and surveillance protocols for neoplasia in IBD.
• Review of treatment considerations for concurrent IBD and cancer.

Main Results:

• Patients with IBD have a significantly increased risk of developing various cancers.
• Early diagnosis and management of colorectal neoplasia are crucial for IBD patients.
• Therapeutic strategies must be carefully considered for IBD patients with active or recent cancer.

Conclusions:

• Inflammatory bowel disease is associated with a broad range of cancers, necessitating vigilant monitoring.
• Effective management of IBD-associated cancers requires a multidisciplinary approach.
• Further research is needed to optimize cancer prevention and treatment in IBD populations.